Literature DB >> 27501831

TREM2 p.H157Y Variant and the Risk of Alzheimer's Disease: A Meta-Analysis Involving 14,510 Subjects.

Teng Jiang1, Jian-Kang Hou, Qing Gao, Jin-Tai Yu, Jun-Shan Zhou, Hong-Dong Zhao, Ying-Dong Zhang2.   

Abstract

We recently revealed that p.H157Y (rs2234255), a rare coding variant of triggering receptor expressed on myeloid cells 2 gene (TREM2), was associated with Alzheimer's disease (AD) susceptibility in Han Chinese. Contrastingly, although p.H157Y was previously identified in both AD cases and controls by several sequencing studies, no association of this variant with disease susceptibility was reported. To gain a credible conclusion on the association between p.H157Y and AD risk, a meta-analysis involving 7,102 cases and 7,408 controls was conducted. Our results indicated that p.H157Y was associated with an increased risk of AD (OR=3.65, 95% CI: 1.61-8.28; P=0.002), further establishing TREM2 as an important susceptibility gene for this disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27501831     DOI: 10.2174/1567202613666160808095530

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  11 in total

Review 1.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

Review 2.  Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.

Authors:  Yihan Li; Simon M Laws; Luke A Miles; James S Wiley; Xin Huang; Colin L Masters; Ben J Gu
Journal:  Cell Mol Life Sci       Date:  2021-10-27       Impact factor: 9.207

3.  EXOC3L2 rs597668 variant contributes to Alzheimer's disease susceptibility in Asian population.

Authors:  Qing-Jian Wu; Shu-Yin Sun; Cheng-Jun Yan; Zi-Cui Cheng; Ming-Feng Yang; Zi-Fei Li; Hou-Wen Cheng; Ti-Kun Fang
Journal:  Oncotarget       Date:  2017-03-21

4.  Genetic and Expression Analysis of COPI Genes and Alzheimer's Disease Susceptibility.

Authors:  Yu Yang; Xu Wang; Weina Ju; Li Sun; Haining Zhang
Journal:  Front Genet       Date:  2019-09-19       Impact factor: 4.599

5.  Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE ε4.

Authors:  Milica A Margeta; Sophia M Letcher; Robert P Igo; Jessica N Cooke Bailey; Louis R Pasquale; Jonathan L Haines; Oleg Butovsky; Janey L Wiggs
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

Review 6.  Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants.

Authors:  Julie Hoogmartens; Rita Cacace; Christine Van Broeckhoven
Journal:  Alzheimers Dement (Amst)       Date:  2021-02-20

Review 7.  TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation.

Authors:  Lorenza Magno; Tom D Bunney; Emma Mead; Fredrik Svensson; Magda N Bictash
Journal:  Mol Neurodegener       Date:  2021-04-06       Impact factor: 14.195

8.  PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages.

Authors:  Juliane Obst; Hazel L Hall-Roberts; Thomas B Smith; Mira Kreuzer; Lorenza Magno; Elena Di Daniel; John B Davis; Emma Mead
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

Review 9.  The Genetics of Alzheimer's Disease in the Chinese Population.

Authors:  Chen-Ling Gan; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

10.  Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population.

Authors:  Xiaopu Zhou; Yu Chen; Fanny C F Ip; Nicole C H Lai; Yolanda Y T Li; Yuanbing Jiang; Huan Zhong; Yuewen Chen; Yulin Zhang; Shuangshuang Ma; Ronnie M N Lo; Kit Cheung; Estella P S Tong; Ho Ko; Maryam Shoai; Kin Y Mok; John Hardy; Vincent C T Mok; Timothy C Y Kwok; Amy K Y Fu; Nancy Y Ip
Journal:  Alzheimers Dement (Amst)       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.